Press "Enter" to skip to content

Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation

Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group and its partner American Regent, Inc., a Daiichi Sankyo Group company, today announced that they have reached settlement agreements with Mylan Laboratories Ltd., and Sandoz, Inc., that resolve the patent litigation brought in response to Abbreviated New Drug Applications seeking approval by the U.S. Food and Drug Administration to market a generic version of Injectafer®.

Under the terms of the settlements, V…


– 출처 : https://www.newswire.co.kr/newsRead.php?no=936851&sourceType=rss